CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 911 - 920 of 1136
Study Number Lead Group Study Title CIRB Study Status
NWU21-08-01 CLO-Northwestern University Phase II Trial of Oral Iloprost for the Precision Chemoprevention of Lung Cancer Cancer Prevention and Control CIRB Available to Open
10302 ETCTN Phase II Trial of Radium-223 Dichloride in Combination with Paclitaxel in Patients with Bone Metastatic Breast Cancer Adult CIRB - Early Phase Emphasis Available to Open
A071401 Alliance Phase II Trial of SMO/AKT/NF2/CDK Inhibitors in Progressive Meningiomas with SMO/AKT/NF2/CDK Pathway Mutations Adult CIRB - Early Phase Emphasis Available to Open
MAY2016-07-01 CP-CTNet_CLO-Mayo Clinic Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Completed
NRG-GU002 NRG Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation following Radical Prostatectomy with or without Adjuvant Docetaxel Adult CIRB - Late Phase Emphasis Available to Open
A022106 Alliance Phase II/III Second-Line NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM) Adult CIRB - Late Phase Emphasis Available to Open
NRG-GI005 NRG Phase II/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA) Adult CIRB - Late Phase Emphasis Available to Open
INT21-05-01 CLO-Northwestern University Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccine (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome Cancer Prevention and Control CIRB Available to Open
UWI2016-07-01 CP-CTNet_CLO-University of Wisconsin Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment Cancer Prevention and Control CIRB Completed
NWU2015-06-04 CLO-Northwestern University Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast Cancer Prevention and Control CIRB Available to Open
Displaying 911 - 920 of 1136